Table 3.
Clinical outcome of mildly stimulated IVF/M cycle in Group A (PCOS) and Group B (non-PCOS) patients
| Groups | A (PCOS) (n=58) |
B (non-PCOS) (n=56) |
P value |
|---|---|---|---|
| No. of IVM/ET cycles | 56 | 57 | NS |
| Clinical pregnancy rate | |||
| Cumulative rate | (20/56) 35.7% | (22/57) 38.5% | NS |
| Fresh ET rate | (7/21) 33.3% | (6/23) 26.1% | NS |
| Frozen ET rate | (13/35) 37.1% | (16/34) 47.1% | NS |
| No. of embryo transferred | 83 | 75 | NS |
| No. of embryo implanted | 20 | 24 | NS |
| Implantation rate | |||
| Cumulative rate | (20/83) 24.1% | (24/75) 32% | NS |
| Fresh ET rate | (7/37) 18.9% | (6/35) 17.1%* | NS |
| Frozen ET rate | (13/46) 28.2% | (18/40) 45%* | NS |
| No. of IVF/ET cycles | 21 | 24 | |
| Clinical pregnancy rate | (11/21) 52.3% | (12/24) 50% | NS |
| Implantation rate | (11/25) 44% | (12/25) 48% | NS |
| Total no. of ET cycles | 77 | 81 | |
| Cumulative pregnancy rate | (31/77) 40.2% | (34/81) 41.9% | NS |
| Cumulative implantation rate | (31/108) 28.7% | (36/100) 36 % | NS |
| No. of biochemical pregnancy | (33/77) (42.8%) | (35/81) (43.2%) | NS |
| No. of miscarriage | (3/33) (9%) | )2/35) (5.8%) | NS |
| No. of livebirth | 9 | 10 | NS |
| No. of ongoing pregnancy | 20 | 23 | |
Data measured by percentage (%); NS represent (P-value > 0.05)
N.B: * represent significant difference between implantation rate of fresh and frozen ET in group B (P <0.05)